SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 12:00 PM ISTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
Pfizer epilepsy drug Lyrica fails in phase III trial Medical Dialogues Bureau28 May 2019 9:00 AM ISTNew Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
Zydus Cadila gets tentative USFDA nod to Lacosamide tablets to treat seizures Farhat Nasim8 April 2019 10:00 AM ISTLacosamide is an anti convulsant or anti-epileptic drug, used to prevent and control seizures. It works by reducing the spread of seizure activity in...
Lupin receives FDA approval for Clobazam Oral Suspension Farhat Nasim1 Jan 2019 10:00 AM ISTLupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
Zydus gets USFDA nod for seizure, migraine drug Ruby Khatun Khatun28 Nov 2017 1:53 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
